ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY ABNORMAL

This adverse event was reported 13 times

ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY ABNORMAL is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TREOSULFAN 1 0.0004
1 BASILIXIMAB 1 0.0001
2 EPOPROSTENOL 1 0.0001
3 IRINOTECAN HYDROCHLORIDE 1 0.0001
4 FLUDARABINE PHOSPHATE 1 0.0000
5 AZATHIOPRINE 2 0.0000
6 ENOXAPARIN SODIUM 1 0.0000
7 MELOXICAM 1 0.0000
8 LETROZOLE 1 0.0000
9 TACROLIMUS OINTMENT 0.1% 2 0.0000
See all drugs enriched for association with ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY ABNORMAL